COURTNEY TESSMER: Open Payments
NPI 1720537731 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,015 in 71 payments from 11 companies in 2025. Trend: 2023 $357 · 2024 $512 · 2025 $2,015
Food & beverage: $2,015
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $521 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $516 |
| Lundbeck LLC | 11 | $278 |
| Alkermes, Inc. | 7 | $229 |
| Axsome Therapeutics, Inc. | 5 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $81 |
| Corium, LLC | 4 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
Products named: VRAYLAR, CAPLYTA, REXULTI, LYBALVI, Auvelity, TRINTELLIX, Azstarys, FANAPT.
Industry payments across MI — which companies pay providers there.
